Clinical validation of a novel automated cell‐free DNA screening assay for trisomies 21, 13, and 18 in maternal plasma

OBJECTIVE: To evaluate clinical performance of a new automated cell‐free (cf)DNA assay in maternal plasma screening for trisomies 21, 18, and 13, and to determine fetal sex. METHOD: Maternal plasma samples from 1200 singleton pregnancies were analyzed with a new non–sequencing cfDNA method, which is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Prenat Diagn
Main Authors: Ericsson, Olle, Ahola, Tarja, Dahl, Fredrik, Karlsson, Filip, Persson, Fredrik, Karlberg, Olof, Roos, Fredrik, Alftrén, Ida, Andersson, Björn, Barkenäs, Emelie, Boghos, Ani, Brandner, Birgit, Dahlberg, Jenny, Forsgren, Per‐Ola, Francois, Niels, Gousseva, Anna, Hakamali, Faizan, Janfalk‐Carlsson, Åsa, Johansson, Henrik, Lundgren, Johanna, Mohsenchian, Atefeh, Olausson, Linus, Olofsson, Simon, Qureshi, Atif, Skarpås, Björn, Svahn, Peter, Sävneby, Anna, Åström, Eva, Sahlberg, Anna, Fianu‐Jonasson, Aino, Gautier, Jérémie, Costa, Jean‐Marc, Jacobsson, Bo, Nicolaides, Kypros
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899636/
https://ncbi.nlm.nih.gov/pubmed/31429096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pd.5528
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados